1-9 of 9
N Singh
Close
Sort by
Journal Articles

Primary and Secondary Plasma Cell Leukemia Risk Stratification By Circulating Plasma Cells

Andrew Y Li, Farin Kamangar, Noa G. Holtzman, Aaron P. Rapoport, Mehmet H. Kocoglu, Djordje Atanackovic, Zeba N Singh, Sameer Sawhney, Ying S Zou, Ashraf Z. Badros
Journal: Blood
Blood (2023) 142 (Supplement 1): 6627.
https://doi.org/10.1182/blood-2023-178314
Published: 2023
Journal Articles

A Subset of Classical Hodgkin Lymphoma Cases Demonstrate CD19 Expression on Hodgkin Reed-Sternberg Cells By Immunohistochemistry

Sarah Helman, Fikru Merechi, Hanan Alharthy, Madhurima Koka, Michael Kallen, Aaron P. Rapoport, Jennie Law, Seung Tae Lee, Zeba N Singh
Journal: Blood
Blood (2023) 142 (Supplement 1): 6125.
https://doi.org/10.1182/blood-2023-174284
Published: 2023
Journal Articles

B-acute lymphoblastic leukemia with eosinophilic inclusions

Sarah R. Helman, Zeba N. Singh
Journal: Blood
Blood (2023) 141 (13): 1645.
https://doi.org/10.1182/blood.2022018796
Published: 2023
Journal Articles

CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma

Clinical Trials & Observations
Craig S. Sauter, Brigitte Senechal, Isabelle Rivière, Ai Ni, Yvette Bernal, Xiuyan Wang, Terence Purdon, Malloury Hall, Ashvin N. Singh, Victoria Z. Szenes, Sarah Yoo, Ahmet Dogan, Yongzeng Wang, Craig H. Moskowitz, Sergio Giralt, Matthew J. Matasar, Miguel-Angel Perales, Kevin J. Curran, Jae Park, Michel Sadelain, Renier J. Brentjens
Journal: Blood
Blood (2019) 134 (7): 626–635.
https://doi.org/10.1182/blood.2018883421
Published: 2019
Includes: Supplemental data
Journal Articles

Non-Producing Multiple Myeloma (MM) Is a Distinct Subset Of Non-Secretory MM Characterized By High Cyclin D1 Expression and Decreased Progression Free Survival

Xenofon Papanikolaou, MD, Qing Zhang, PhD, Christoph Heuck, MD, Sarah Waheed, MD, Shebli Atrash, MD, Zeba N Singh, MD, Daisy V. Alapat, MD, Frits van Rhee, MD, PhD, Shweta S. Chavan, PhD, Joshua Epstein, DSc, Bart Barlogie, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1911.
https://doi.org/10.1182/blood.V122.21.1911.1911
Published: 2013
Journal Articles

Fulminant Onset of Acute Leukemia (FOAL) After Total Therapies (TT) for Multiple Myeloma (MM): Absence of MDS Pathological Criteria within 3 Months of Prior MM Follow-up

Zeba N Singh, MD, Jeffrey R Sawyer, Ph.D., Ginell R. Post, MD, PhD, Sarah Waheed, MD, Saad Z Usmani, MD FACP, Frits van Rhee, MD, PhD, Bart Barlogie, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1458.
https://doi.org/10.1182/blood.V120.21.1458.1458
Published: 2012
Journal Articles

Secondary Myelodysplasia-Associated Metaphase Cytogenetic Abnormalities in Newly Diagnosed Multiple Myeloma Treated On Total Therapies 2 & 3– Influence of Cumulative Dosing of Maintenance Drugs

Saad Z Usmani, MD FACP, Adam Rosenthal, Rachael Sexton, Antje Hoering, Zeba N Singh, MD, Sarah Waheed, MD, Al-Ola Abdallah, MD, Jameel Muzaffar, MD, Nathan M Petty, John Crowley, PhD, Jeffrey Sawyer, PhD, Joshua Epstein, DSc, Frits van Rhee, MD, PhD, Bart Barlogie, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 324.
https://doi.org/10.1182/blood.V120.21.324.324
Published: 2012
Journal Articles

Loss of Chemokine Receptor Expression and Tetraspanins Is Correlated with Extramedullary Disease In Multiple Myeloma

Zeba N Singh, MD, Rebecca B Owens, BSMT, Bijay Nair, MD, MPH, John Shaughnessy, Jr., PhD, Bart Barlogie, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2983.
https://doi.org/10.1182/blood.V116.21.2983.2983
Published: 2010
Journal Articles

The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma

M Du, H Peng, N Singh, PG Isaacson, L Pan
Journal: Blood
Blood (1995) 86 (12): 4587–4593.
https://doi.org/10.1182/blood.V86.12.4587.bloodjournal86124587
Published: 1995